Home
Reel
Gruppi
Pagine
Mostra tutto
Gruppi Pagine I miei blog Le mie offerte I miei lavori I miei corsi Eventi Blog Offerte Lavori Corsi Forum Film Giochi
Accedi Iscriviti
Modalità giorno
TUDRIQEV Approval for Advanced Melanoma: Regulatory Progress, Mechanism, and Clinical Outlook
Replimune has reached an important milestone in oncology with the FDA’s accelerated approval of tudriqev (vusolimogene oderparepvec-wtpg), previously identified as RP1, in combination with Bristol Myers Squibb’s OPDIVO (nivolumab). Granted on August 6, 2026, the approval applies to adults with unresectable, advanced cutaneous melanoma that has progressed after treatment with an...
0 Commenti ·0 Condivisioni ·216 Visualizzazioni ·0 Recensioni
Effettua l'accesso per mettere mi piace, condividere e commentare!
Villagge https://villagge.com